Quarry LP’s Ionis Pharmaceuticals IONS Stock Holding History

Quarry LP’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.3K	Buy	+29	New	+$2.18K	﹤0.01%	1551
2026 Q1	–	Sell	-180	Closed	-$14.2K	–	1836
2025 Q4	$14.2K	Sell	180 -408	-69%	-$30.7K	﹤0.01%	1212
2025 Q3	$38.5K	Buy	+588	New	+$28.7K	0.01%	993
2025 Q2	–	Sell	-3,000	Closed	-$90.5K	–	1876
2025 Q1	$90.5K	Sell	3,000 -3,000	-50%	-$98.2K	0.02%	555
2024 Q4	$210K	Buy	+6,000	New	+$224K	0.03%	239
2024 Q1	–	Sell	-200	Closed	-$10.1K	–	1771
2023 Q4	$10.1K	Sell	200 -1,300	-87%	-$62.3K	﹤0.01%	1065
2023 Q3	$68K	Buy	+1,500	New	+$61.9K	0.02%	258

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Quarry LP's IONS Position: Q2 2026 in Review

Quarry LP opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 29 shares worth $2.3K. The stake represents ﹤0.01% of the portfolio and ranks #1551 among its holdings. This is a return to the name: Quarry LP previously reported a position in IONS as recently as Q4 2025.

Quarry LP first reported a position in IONS in Q3 2023 and has held it in 7 quarters since. The position peaked at $210K in Q4 2024. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Quarry LP held 29 shares of Ionis Pharmaceuticals worth $2.3K as of Q2 2026.
Ionis Pharmaceuticals was a new Quarry LP position in Q2 2026.
Ionis Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1551 holding.
Quarry LP first reported a position in Ionis Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
Quarry LP's Ionis Pharmaceuticals position peaked at $210K in Q4 2024.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.